HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brandon Antonakos Selected Research

NVP-CGM097

10/2015Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brandon Antonakos Research Topics

Disease

4Neoplasms (Cancer)
01/2023 - 06/2014
1Leukemia
10/2015

Drug/Important Bio-Agent (IBA)

1Transcription Factors (Transcription Factor)IBA
01/2023
1SHP099IBA
01/2016
1Phosphotransferases (Kinase)IBA
01/2016
1tyrosine receptor (receptor, tyrosine)IBA
01/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2016
1Non-Receptor Type 11 Protein Tyrosine PhosphataseIBA
01/2016
1Proteins (Proteins, Gene)FDA Link
10/2015
1NVP-CGM097IBA
10/2015
1TankyrasesIBA
06/2014
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
06/2014

Therapy/Procedure

1Immunotherapy
01/2023
1Therapeutics
01/2016